Influenza (seasonal)

La grippe menace toujours le monde malgré un nombre grandissant de vaccinations

«Nous sommes assurément mieux préparés» qu’il y a dix ans, a dit la sous-directrice générale de l’Organisation mondiale de la santé (OMS) Marie-Paule Kieny. Mais il reste beaucoup à faire, selon elle.
 
De trois à cinq millions de cas d’infections humaines sont observés de décembre à mai, a dit une responsable du département des pandémies à l’OMS, Wenqing Zhang. Les virus circulent par les oiseaux sauvages ou domestiques. De la grippe aviaire aux autres souches, 17 types et 11 sous-types peuvent être combinés.
 
Undefined

Seasonal influenza vaccines market will hit $4.3 billion by 2025, says GlobalData

The seasonal influenza vaccine market across the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK, and Japan, will rise from $3.1 billion in 2015 to $4.3 billion by 2025, at a compound annual growth rate of 3.3%, according to research and consulting firm GlobalData.

Undefined

Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
 
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.
 
Undefined

Vaccine in National Immunization Programme Update

WHO, UNICEF, and partners, are in regular dialogue with countries to support effective preparations.

Click here to access the downloadable PowerPoint file from the WHO website or simply click on the image below to read updates on vaccine in national immunization programmes.

Undefined

China needs tougher enforcement of vaccine regulation: WHO

China must strengthen regulation of its market for vaccines, the World Health Organization (WHO) said on Monday, after a bust of an illegal black market drugs ring this month underscored the country's regulatory weaknesses.
 
Police have arrested more than 130 suspects over a scandal in which 310 million yuan ($48 million) of illegal vaccines was sold onto the market. The value of the illegal trades could be as much as $90 million.
 
Undefined

Afrique: Vaccination infantile - L'Afrique, le continent le moins protégé

La première conférence ministérielle africaine sur la vaccination a ouvert ses travaux, le mercredi 24 février 2016 à Addis Abeba en Ethiopie. Des ministres de la Santé, des Finances, des experts, des décideurs, des bailleurs de fonds et de la société civile réfléchissent aux moyens les plus efficaces afin de parvenir à une couverture vaccinale de tous les enfants du continent.
 
Etendre la vaccination afin de parvenir à une couverture universelle est le nouveau challenge que les dirigeants africains et leurs partenaires veulent se donner en matière de santé.
Undefined

Grippe aviaire : le Lot, septième département à être touché

Un septième département vient d’être touché par la grippe aviaire. Il s’agit du Lot, a annoncé, mardi 5 janvier, le ministère de l’agriculture sur son site Internet. Le nombre de foyers d’influenza aviaire hautement pathogène pour les volailles se chiffre désormais à 65 dans le Sud-Ouest de la France.
 
Undefined

Roche's influenza A and B tests get federal permission to be used at the point-of-care

Roche's real-time polymerase chain reaction tests for the detection of influenza A and B can now be used in settings such as the emergency room, pharmacies and physicians' offices, thanks to a CLIA waiver exempting it from a set of regulations on large diagnostic laboratories carried out by the federal Centers for Medicare & Medicaid Services.

Undefined

Scripps Research Institute, J&J test 'universal' flu vaccine in mice, monkeys

The NIAID may have posted 94% efficacy in mice for its investigational "universal" flu vaccine, but The Scripps Research Institute and partner Johnson & Johnson ($JNJ) are hot on its heels. Scripps announced Monday that its most advanced candidate fully protected mice in a lethal challenge. They also conducted a sublethal challenge, where the vaccine reduced fever in monkeys.
 
Undefined

Pages